Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Osteosarcoma 6Renal Insufficiency 2Lymphoma 2Leukemia 2Water Intoxication 1Neoplasms 1Mucositis 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Acute Kidney Injury 1

Interventions

apatinib 4Ifosfamide 2Filgrastim 2Etoposide 2selinexor 1glucarpidase 1camrelizumab 1Vincristine 1Radiotherapy 1Procarbazine 1Pharmaceutical Preparations 1Methotrexate 1Lomustine 1Imatinib Mesylate 1Genetic Therapy 1Fibroblast Growth Factor 7 1Drug Combinations 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × glucarpidase × Sarcoma × Clear all
NCT05899751 2024-05-10

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

BTG International Inc.

Unknown
1,000 enrolled
GenitourinaryOther hematologic neoplasmSarcoma

Osteosarcoma, Water Intoxication, Hematologic Neoplasms, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡